Some studies have shown that the level of GDNF increased after 3 months of treatment in patients with first-episode schizophrenia, which was positively correlated with cognitive function, indicating that GDNF may have neuroprotective effects [23]. The gene discussed is GDNF; the disease is schizophrenia.